Search research articles
Contact Us
Filters
Showing results (431-440 of 442) with videos related to
Page
of 45
Sort By:
Scandinavian Journal of Infectious Diseases
|
July 7, 2001
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime
S Cronberg, S Banke, B Bergman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 1999
Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial
G Westman, B Bergman, M Albertsson, et al.
Seminars in Oncology
|
June 1, 1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer
C Manegold, P Drings, J von Pawel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1997
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
C Manegold, B Bergman, A Chemaissani, et al.
The Journal of Biological Chemistry
|
April 12, 2001
Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes
C C Martin, L J Bischof, B Bergman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 24, 1999
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
W W ten Bokkel Huinink, B Bergman, A Chemaissani, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 7, 2022
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
A A Bokhari, W-Y Lai, A T Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors
J von Pawel, R von Roemeling, U Gatzemeier, et al.
Molecular Genetics & Genomic Medicine
|
January 22, 2020
Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development
Jocelyn A van den Bergen, Gorjana Robevska, Stefanie Eggers, et al.
Journal of Autism and Developmental Disorders
|
September 9, 2021
Associations Between Hyperphagia, Symptoms of Sleep Breathing Disorder, Behaviour Difficulties and Caregiver Well-Being in Prader-Willi Syndrome: A Preliminary Study
Jessica Mackay, Gillian M Nixon, Antony R Lafferty, et al.
Page
of 45
Search research articles
Search
Showing results (431-440 of 442) with videos related to
Sort By:
Page
of 45
Scandinavian Journal of Infectious Diseases
|
July 7, 2001
Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime
S Cronberg, S Banke, B Bergman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 24, 1999
Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial
G Westman, B Bergman, M Albertsson, et al.
Seminars in Oncology
|
June 1, 1997
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer
C Manegold, P Drings, J von Pawel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 1, 1997
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer
C Manegold, B Bergman, A Chemaissani, et al.
The Journal of Biological Chemistry
|
April 12, 2001
Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes
C C Martin, L J Bischof, B Bergman, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 24, 1999
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer
W W ten Bokkel Huinink, B Bergman, A Chemaissani, et al.
Lung Cancer (Amsterdam, Netherlands)
|
August 7, 2022
Novel human-derived EML4-ALK fusion cell lines identify ribonucleotide reductase RRM2 as a target of activated ALK in NSCLC
A A Bokhari, W-Y Lai, A T Le, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors
J von Pawel, R von Roemeling, U Gatzemeier, et al.
Molecular Genetics & Genomic Medicine
|
January 22, 2020
Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development
Jocelyn A van den Bergen, Gorjana Robevska, Stefanie Eggers, et al.
Journal of Autism and Developmental Disorders
|
September 9, 2021
Associations Between Hyperphagia, Symptoms of Sleep Breathing Disorder, Behaviour Difficulties and Caregiver Well-Being in Prader-Willi Syndrome: A Preliminary Study
Jessica Mackay, Gillian M Nixon, Antony R Lafferty, et al.
Page
of 45